Sponsor Pipeline

Danatlas Pharmaceuticals Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
7
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07652073 A Study of DAT-2645 in Patients With BRCA1/2 Mutations or HRD-Positive Ovarian Cancer Advanced or Metastatic Ovarian Cancer Not Yet Recruiting
Phase 1
NCT06614751 A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors… Solid Cancers Not Yet Recruiting
NCT06998173 Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary… Advanced Solid Tumors Not Yet Recruiting
Disease Areas
Breast Cancer (1) Prostate Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Endometrial Cancer (1) Ovarian Cancer (1)
Get alerts when Danatlas Pharmaceuticals Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free